International Assets Investment Management LLC Lowers Holdings in GE HealthCare Technologies Inc. $GEHC

International Assets Investment Management LLC cut its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 30.2% during the second quarter, Holdings Channel reports. The firm owned 3,788 shares of the company’s stock after selling 1,641 shares during the quarter. International Assets Investment Management LLC’s holdings in GE HealthCare Technologies were worth $281,000 at the end of the most recent reporting period.

A number of other large investors also recently added to or reduced their stakes in GEHC. JPMorgan Chase & Co. lifted its holdings in GE HealthCare Technologies by 49.9% in the 1st quarter. JPMorgan Chase & Co. now owns 5,140,549 shares of the company’s stock worth $414,894,000 after purchasing an additional 1,711,963 shares in the last quarter. Nuveen LLC bought a new stake in GE HealthCare Technologies in the 1st quarter worth approximately $77,058,000. Eminence Capital LP increased its stake in GE HealthCare Technologies by 38.7% in the 1st quarter. Eminence Capital LP now owns 1,819,129 shares of the company’s stock worth $146,822,000 after acquiring an additional 507,101 shares during the last quarter. Homestead Advisers Corp increased its stake in GE HealthCare Technologies by 92.7% in the 1st quarter. Homestead Advisers Corp now owns 988,600 shares of the company’s stock worth $79,790,000 after acquiring an additional 475,500 shares during the last quarter. Finally, Canada Pension Plan Investment Board increased its stake in GE HealthCare Technologies by 15.2% in the 1st quarter. Canada Pension Plan Investment Board now owns 3,111,398 shares of the company’s stock worth $251,121,000 after acquiring an additional 409,636 shares during the last quarter. 82.06% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of analysts have issued reports on GEHC shares. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of GE HealthCare Technologies in a research note on Tuesday, October 14th. Zacks Research downgraded GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a research note on Monday, September 29th. Morgan Stanley set a $74.00 price objective on GE HealthCare Technologies in a research note on Thursday, September 18th. Citigroup downgraded GE HealthCare Technologies from a “buy” rating to a “neutral” rating and reduced their price objective for the stock from $93.00 to $83.00 in a research note on Tuesday, October 7th. Finally, Barclays initiated coverage on GE HealthCare Technologies in a research note on Monday, October 13th. They issued an “equal weight” rating and a $86.00 price objective on the stock. Six equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $85.20.

GE HealthCare Technologies Stock Performance

Shares of GE HealthCare Technologies stock opened at $77.26 on Friday. The stock’s fifty day moving average is $74.68 and its two-hundred day moving average is $72.30. The company has a market capitalization of $35.27 billion, a PE ratio of 15.83, a price-to-earnings-growth ratio of 2.91 and a beta of 1.13. The company has a quick ratio of 0.93, a current ratio of 1.16 and a debt-to-equity ratio of 0.85. GE HealthCare Technologies Inc. has a 52 week low of $57.65 and a 52 week high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings data on Wednesday, July 30th. The company reported $1.06 EPS for the quarter, beating the consensus estimate of $0.91 by $0.15. The company had revenue of $5 billion for the quarter, compared to the consensus estimate of $4.96 billion. GE HealthCare Technologies had a return on equity of 23.93% and a net margin of 11.22%.GE HealthCare Technologies’s quarterly revenue was up 3.5% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.00 EPS. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. As a group, analysts expect that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Shareholders of record on Friday, October 24th will be given a $0.035 dividend. This represents a $0.14 annualized dividend and a yield of 0.2%. The ex-dividend date of this dividend is Friday, October 24th. GE HealthCare Technologies’s dividend payout ratio is 2.87%.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.